September 3, 2009 (FinancialWire) — Medical device maker NuVasive, Inc. (NASDAQ: NUVA) said that Kevin O’Boyle plans to step down as its executive vice president and chief financial officer. The company said it is currently engaged in a search for a new CFO.

According to the company, O’Boyle plans to remain with NuVasive until December 31, or potentially longer, to assist in the recruitment of his replacement and to effect an orderly transition.

San Diego-based NuVasive is focused on the design, development and marketing of products for the surgical treatment of spine disorders. The company’s product portfolio is focused on applications in the U.S. spine fusion market.

NuVasive’s current principal product offering includes a surgical platform called Maximum Access Surgery, or MAS, as well as an offering of cervical and motion preservation products.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.